Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$52.3K Buy
1,478
+258
+21% +$8K ﹤0.01% 1244
2025
Q4
$34.1K Buy
1,220
+446
+58% +$13.4K ﹤0.01% 1370
2025
Q3
$23.2K Sell
774
-262
-25% -$7.39K ﹤0.01% 1398
2025
Q2
$29.6K Buy
1,036
+114
+12% +$3.39K ﹤0.01% 1268
2025
Q1
$30.4K Sell
922
-485
-34% -$15.8K ﹤0.01% 1226
2024
Q4
$40.5K Hold
1,407
﹤0.01% 994
2024
Q3
$39.4K Buy
1,407
+230
+20% +$6.13K ﹤0.01% 942
2024
Q2
$28.4K Buy
1,177
+109
+10% +$2.67K ﹤0.01% 960
2024
Q1
$28.9K Buy
1,068
+68
+7% +$1.93K ﹤0.01% 965
2023
Q4
$27.7K Hold
1,000
﹤0.01% 968
2023
Q3
$28K Hold
1,000
﹤0.01% 982
2023
Q2
$31.3K Hold
1,000
﹤0.01% 970
2023
Q1
$28.2K Hold
1,000
﹤0.01% 988
2022
Q4
$26K Sell
1,000
-1,000
-50% -$23.9K ﹤0.01% 1014
2022
Q3
$45K Hold
2,000
﹤0.01% 896
2022
Q2
$60K Hold
2,000
﹤0.01% 860
2022
Q1
$53K Hold
2,000
﹤0.01% 955
2021
Q4
$47K Buy
+2,000
New +$52.6K ﹤0.01% 1014

Other funds holding ALKS

UMB Bank's ALKS Position: Q1 2026 in Review

UMB Bank increased its Alkermes (ALKS) stake by 21% in Q1 2026, buying an estimated $8K and bringing the position to 1,478 shares worth $52.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1244.

UMB Bank first reported a position in ALKS in Q4 2021 and has held it in 18 quarters since. The position peaked at $60K in Q2 2022. 388 funds tracked by Wall St. Rank hold ALKS as of Q1 2026.

  • UMB Bank held 1,478 shares of Alkermes worth $52.3K as of Q1 2026.
  • UMB Bank bought 258 Alkermes shares in Q1 2026, an estimated $8K.
  • Alkermes made up ﹤0.01% of UMB Bank's portfolio in Q1 2026, its #1244 holding.
  • UMB Bank first reported a position in Alkermes in Q4 2021 and has held it in 18 quarters since.
  • UMB Bank's Alkermes position peaked at $60K in Q2 2022.
  • 388 funds tracked by Wall St. Rank held Alkermes as of Q1 2026.

Based on UMB Bank's 13F filing for Q1 2026, filed 11 May 2026.